We are one of eight Healthcare Technology Co-operatives (HTCs) funded by the National Institute for Health Research (NIHR) to act as a centre of expertise that focus in clinical areas of high morbidity and unmet need for NHS patients.

The aims of the NIHR Trauma Management HTC are to:

  • act as a catalyst for NHS “pull’’ for the development of new medical devices, healthcare technologies and technology-dependent interventions
  • improve the quality of life and effectiveness of healthcare services for trauma patients from pre-hospital through to rehabilitation in the home
  • work collaboratively with patients and patient groups, charities, industry, clinicians and academics.


  • Poll

    A national poll to help us identify unmet clinical need in trauma will be available shortly.

  • Point-of-Care FBC Survey

    Please click on link to take survey



More events
  • 22Nov

    MIDOs Patient Reference Group

    22 November 2016

    On 25th October, Trauma Management Healthcare Technology Co-operative (HTC) held a patient reference group for the Minimally Invasive Delivery of Osteospheres (MIDOs) project. The MIDOs project is aimed at creating a revolutionary way of preventing osteoporosis in…

  • 15Jun

    New 28th July SBRI Funding Calls

    15 June 2016

    The SBRI are looking to award a total of £1.1 million for healthcare innovations that address challenges in the high need areas of ‘Managing patient flow in acute care’ and ‘Self-care and independence for children with long-term…


More news
  • Tom Clutton-Brock in Top 100 Health Tech Innovators

    09 August 2016

      Trauma HTC Clinical Director, Dr. Tom Clutton-Brock, has been named among the world’s top 100 health technology innovators. Reported by University Hospitals Birmingham NHS Foundation Trust Research and Innovation, the list of innovators is…

  • International Clinical Trials day 2014

    23 May 2014

    Queen Elizabeth Hospital, University Hospitals Birmingham 20th May 2014 For the second year running, the HTC participated in the International Clinical Trials Day. The HTC had a strong presence in the main atrium of the…